Ariana Resources plc is an AIM-listed gold exploration and development company. Ariana's advanced projects are located in western Turkey.  Production is currently scheduled to start on the Red Rabbit Gold Project following receipt of permits in 2015.  Ongoing exploration is fulfilled through our own work in western Turkey, via joint venture (Eldorado Gold) and strategic investment (Tigris Resources).  Ariana is spearheaded by an experienced management team, which aims to discover and develop new gold mines.

Avacta’s focus is on its proprietary Affimer® platform technology, a novel engineered alternative to antibodies, that has wide application in diagnostics, therapeutics and research.

Antibodies dominate markets worth more than $75bn despite their shortcomings. Affimer technology, based on a small, robust protein, can be quickly generated to bind with high specificity and affinity to a wide range of targets, addressing many of the limitations of antibodies.

Avacta has a pre-clinical Affimer drug development programme with a focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of research tools and diagnostics.

eg solutions is a back office workforce optimisation software company. eg pioneered this new market space and developed the most complete, purpose built workforce optimisation software for back offices – the only solution that manages work, people and end-to-end processes wherever they are undertaken, anywhere in the world.

Our software is used by leading UK, international and global companies in multiple industry sectors.

Using our forecasting, scheduling, real-time work management and operational analytics capabilities we deliver measureable improvements in service, quality, productivity and regulatory compliance. When supported by our implementation and training services we guarantee return on investment.